Literature DB >> 24063970

Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients--based on a hospital study in China.

Z Song1, H Zhu, Z Guo, W Wu, W Sun, Y Zhang.   

Abstract

AIMS: We investigated the relationship between predominant subtype, according to the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification, and prognosis in stage I lung adenocarcinoma in Zhejiang Cancer Hospital.
METHODS: Two hundred and sixty-one patients with stage I lung adenocarcinoma, operated in Zhejiang Cancer Hospital, were identified between 2000 and 2010. Survival curves were plotted using the Kaplan-Meier method. The Cox proportional hazard model was used for multivariate analysis.
RESULTS: None of the cases were adenocarcinoma in situ and six were minimally invasive adenocarcinomas. Two hundred and fifty-five cases were invasive adenocarcinoma. Of those, 80, 76, 42, 34, 19, and 4 were papillary predominant, acinar predominant, micropapillary predominant, solid predominant, lepidic predominant subtypes, and variants of invasive adenocarcinoma, respectively. Patients with micropapillary and solid predominant tumors had a significantly worse disease-free survival as compared to those with other subtypes predominant tumors (p < 0.001). Multivariate analysis revealed that the new classification was an independent predictor of the disease-free and overall survival (p = 0.002 and 0.015).
CONCLUSION: The predominant subtype in the primary tumor was associated with prognosis in resected stage I lung adenocarcinoma. Published by Elsevier Ltd.

Entities:  

Keywords:  IASLC/ATS/ERS classification; Non-small cell lung cancer; Prognosis

Mesh:

Year:  2013        PMID: 24063970     DOI: 10.1016/j.ejso.2013.08.026

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  32 in total

1.  Histological subtypes of solitary pulmonary nodules of adenocarcinoma and their clinical relevance.

Authors:  Hui-Di Hu; Ming-Yue Wan; Chun-Hua Xu; Ping Zhan; Jue Zou; Qian-Qian Zhang; Yuan-Qing Zhang
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

Review 2.  Advances in lung adenocarcinoma classification: a summary of the new international multidisciplinary classification system (IASLC/ATS/ERS).

Authors:  Elizabeth R Tang; Andrew M Schreiner; Bradley B Pua
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

Review 3.  The new IASLC/ATS/ERS lung adenocarcinoma classification from a clinical perspective: current concepts and future prospects.

Authors:  Jon Zugazagoitia; Ana Belen Enguita; Juan Antonio Nuñez; Lara Iglesias; Santiago Ponce
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

Review 4.  Implementing the new IASLC/ATS/ERS classification of lung adenocarcinomas: results from international and Chinese cohorts.

Authors:  Ming-Ching Lee; Kyuichi Kadota; Daniel Buitrago; David R Jones; Prasad S Adusumilli
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

5.  The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know.

Authors:  Takashi Eguchi; Kyuichi Kadota; Bernard J Park; William D Travis; David R Jones; Prasad S Adusumilli
Journal:  Semin Thorac Cardiovasc Surg       Date:  2014-09-16

Review 6.  Clinical impact of the new IASLC/ATS/ERS lung adenocarcinoma classification for chest surgeons.

Authors:  Haruhiko Nakamura; Masayuki Takagi
Journal:  Surg Today       Date:  2014-11-23       Impact factor: 2.549

7.  Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection.

Authors:  Ming-Sound Tsao; Sophie Marguet; Gwénaël Le Teuff; Sylvie Lantuejoul; Frances A Shepherd; Lesley Seymour; Robert Kratzke; Stephen L Graziano; Helmut H Popper; Rafael Rosell; Jean-Yves Douillard; Thierry Le-Chevalier; Jean-Pierre Pignon; Jean-Charles Soria; Elisabeth M Brambilla
Journal:  J Clin Oncol       Date:  2015-04-27       Impact factor: 44.544

Review 8.  Concordant and Discordant EGFR Mutations in Patients With Multifocal Adenocarcinomas: Implications for EGFR-Targeted Therapy.

Authors:  Jody C Chuang; Joseph B Shrager; Heather A Wakelee; Joel W Neal
Journal:  Clin Ther       Date:  2016-06-29       Impact factor: 3.393

Review 9.  Surgical pathology of early stage non-small cell lung carcinoma.

Authors:  Mary Beth Beasley; Francine R Dembitzer; Raja M Flores
Journal:  Ann Transl Med       Date:  2016-06

10.  Expansion of the Concept of Micropapillary Adenocarcinoma to Include a Newly Recognized Filigree Pattern as Well as the Classical Pattern Based on 1468 Stage I Lung Adenocarcinomas.

Authors:  Katsura Emoto; Takashi Eguchi; Kay See Tan; Yusuke Takahashi; Rania G Aly; Natasha Rekhtman; William D Travis; Prasad S Adusumilli
Journal:  J Thorac Oncol       Date:  2019-07-25       Impact factor: 15.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.